BMJ1d
Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis
Background: Mild cognitive impairment (MCI) is a condition that carries a substantial risk of dementia. The exact magnitude of that risk is uncertain because of the variations in the definition of MCI ...
BMJ1d
Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease
Objective Traumatic brain injury (TBI) and rapid eye movement sleep behavioural disorder (RBD) are risk factors for Parkinson’s disease (PD). Dopaminergic abnormalities are often seen after TBI, but ...
BMJ2d
The long term retention of levetiracetam in a large cohort of patients with epilepsy
Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, and the National Hospital for Neurology and Neurosurgery, London, UK Correspondence to: Professor Ley Sander Department of ...
BMJ2d
Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis
Department of Neurosurgery, Istituto Nazionale Neurologico C. Besta, Milan, Italy Dr Giovanni Broggi, Department of Neurosurgery, Istituto Nazionale Neurologico C Besta, Via Celoria 11, 20133 Milan, ...
BMJ4d
Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: a critical review
a Secure Care Program, Department of Psychiatry, Taunton State Hospital, Taunton, MA, USA, and Harvard Medical School, Boston, MA, USA, b Departments of Neurology ...
BMJ4d
Open-label trial of anterior limb of internal capsule–nucleus accumbens deep brain stimulation for obsessive-compulsive disorder: insights gained
Background For more than 15 years, deep brain stimulation (DBS) has served as a last-resort treatment for severe treatment-resistant obsessive-compulsive disorder (OCD). Methods From 2010 to 2016, 20 ...
BMJ5d
Frontal lobe syndrome reassessed: comparison of patients with lateral or medial frontal brain damage
Dr Sergio Paradiso, University of Iowa College of Medicine Psychiatry Research, MEB, Iowa City, IA 52241, USA. Telephone 001 319 353 4446; fax 001 319 353 3003; email sergio-paradiso{at}uiowa.edu ...
BMJ5d
Efficacy of pulse intravenous methylprednisolone in epileptic encephalopathy: a randomised controlled trial
Correspondence to Dr Sanjib Sinha, Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India; sanjib_sinha2004{at}yahoo.co.in Background High-level ...
BMJ6d
CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease
Background Synaptosomal-associated protein 25 (SNAP-25) in cerebrospinal fluid (CSF) is an emerging synaptic biomarker for the early diagnosis of Alzheimer’s disease (AD). However, comprehensive ...
BMJ6d
Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer’s disease：a systematic review with meta-analysis
Correspondence to Dr Ya Miao, Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China; nning-my{at}163.com; Prof Qihao Guo, Department of Geriatrics ...
BMJ7d
Long-term trajectories of decline in cognition and daily functioning before and after stroke
Objective Although knowledge on poststroke cognitive and functional decline is increasing, little is known about the possible decline of these functions before stroke. We determined the long-term ...